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INTRODUCTION 
The article by Hill, Rowlands and Rifkind 1 was a 
by-product of an institutional commitment to transplan-
tation in 1961-63, at the University of Colorado 
(Denver). The programme was launched after the 
ostensible fantasy of exploiting transplant procedures 
clinically had been demonstrated to be occasionally 
feasible at the Peter Bent Brigham Hospital in Boston 
(Joseph Murray and John Merrill),2.3 and at the Paris 
centres directed by Jean Hamburger4 .5 and Rene Kuss.6 
Between January 1959. and the summer of 1962, seven 
examples had been produced (two in Boston, five in 
Paris) of patient survival exceeding 6 months following 
human kidney transplantation, all but one after recipient 
cytoablation with total body irradiation (Table 1). 
The seventh recipient, treated in Boston by Murray, 
was unique in that the patient was immunosuppressed 
from the outset with daily doses of the 6-mercaptopurine 
derivative, azathioprine? This therapeutic option, which 
evolved from the basic investigations in rodents by 
Schwartz and Dameshek,8.9 and of Meeker and Good 
et ai.,l0 had been greeted initially with feverish enthusi-
asm. in part because it had been recognized that the 
strategy of cytoablation with total body irradiation 
would permit success in only occasional cases of human 
renal transplantation. The only evidence that this could 
be achieved in animals was the survival for 73 days of a 
beagle dog before dying of pneumonia reported by 
Mannick et (Ii. II However, this animal also had been 
given donor bone marrow and was suspected of having 
received the allograft from a closely related donor. 12 
Abbreviation used: GVHD, graft versus host disease. 
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The optimism generated by the new drugs was quickly 
dampened by the results of their preclinical studies by 
Caine 13,14 and Zukoski 15 with the outbred mongrel 
canine kidney transplant model in which only about 5% 
of the dogs survived for ::::: 100 days.16 In Murray's 
clinical trials,16.17 survival did not appear at first to be 
substantially better than with irradiation. Patient 7 in 
Table 1 was the only one of the first ten in Murray's 
clinical trial (two using 6-MP, eight with azathioprine) 
who had ::::: 6 months graft function. An overwhelming 
rate of patient death usually was caused by, or related to, 
infection. 
The dilemma, as it was perceived at the time, is shown 
in Figure 1. It was feared that chronic drug immunosup-
pression powerful enough to prevent organ allograft 
rejection would render the recipient hopelessly vulner-
able to indigenous and environmental pathogens. It also 
was suspected that immune surveillance to tumours 
would be eroded, a possibility that ultimately was 
verified. 18 At the nadir of the consequent pessimism in 
1962-63, two reproducible observations were made at 
the University of Colorado (Denver) that shaped future 
developments in organ transplantation. 19 
First in dogs and then in humans, kidney allograft 
rejection, which had been considered to be one of nature's 
strongest reactions, was shown to be readily reversible by 
adding high doses of prednisone to baseline azathioprine 
therapy. More importantly, the allografts appeared to self 
induce tolerance.19 This was manifested by the ability 
in the Colorado live donor recipients to subsequently 
wean maintenance immunosuppression to doses below 
those which had failed at the outset to prevent rejection. 
Exploitation of these findings resulted in the first series of 
successful renal transplantations. Nine of the first ten 
patients had prolonged survivaj19 and four lived for > 25 
years. 20 Two of the four bear the longest surviving organ 
allografts in the world today (>35 years). These two 
patients, whose transplant operations were separated by a 
9 day interval, have been without immunosuppressive 
drugs for 4 and 32 years, respectively. 
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Table 1. Kidney transplantation;::; 6 months survival as of March 1963 
Survival 
Case CityRe£ Date Donor (months)a 
1. BostonZ.3 24-1-59 Frat twin >50 
2. Paris4 29-6-59 FriJIt twin >45 
3. Paris¢ 22-6-60 Unrelatedb 18 (Died) 
4. Pariss 19-12-60 Motherb 12 (Died) 
5. Paris" 12-3-61 Unrelatedb 18 (Died) 
6. Pariss 12-2-62 Cousinb >13 
7. Boston7 5-4-62 Unrelated 10 
aThe kidneys in patients 1, 2, and 6 functioned for 20.5, 25, and 15 yeiJIts respectively. Patient 7 
rejected his graft after 17 months and died after return to dialysis. 
Boston J. E. Murray (case$ 1 and 7) 
Paris: J. Hamburger (cases 2, 4 and 6) 
R. Kuss (cases 3 and 5) 
b Adjunct steroid therapy. 
All patients received cytoablation with total body irradiation, except number 7 who was given 
azathioprine. 
. . . 
• e. e • 







',': ~ :: .. ::~"::K::K: : '. ...... ... , 
.' :: .. ' .-, •.... ~ 
• • I' •• I' I: .1. I, :: 
. ":':. : .. 
';." 
lMMUJI N 09 1UIPPRlES SION 
(peak. at rejection cri".\is) 
Figure 1. The original caption for this figure: 'Possible mechanisms of simultaneous loss of host reactivity to 
specific strains of endogenous bacteria, as well as to the alien renal tissue: (By permission of Surgery 56, 296, 
1964). 
The early kidney experience triggered the first 
attempts in Colorado in 1963 to replace the liver/I a 
clinical trial with baboon renal xenografts,22 and 
transplantation of the spleen for anti-tumour objectives, 18 
All of these cases were failures, as well as three others in 
which irreparably damaged cadaver kidneys were trans-
planted.23 accounting for almost half of the autopsies in 
the Hill-Rowlands-Rifkind report. In contrast, when the 
high rate of success of the double drug immune sup-
pression (i.e. azathioprine/prednisone) in the live-donor 
kidney cases became known, a world wide proliferation 
of renal transplant centres occurred within the succeeding 
12 months. 
Nevertheless the sober report of Hill, Rowlands and 
Rifkind gave warning that the concept depicted in 
Figure 1 was correct, at least in part. In this autopsy 
collection, infections for which specific antibiotics were 
available had been largely controlled, while opportunistic 
microorganisms of normally low pathogenicity were 
over-represented. Of these, CMV was the most common 
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and lethal, presaging a problem that remains endemic 
today. Although PlZeumocysfis mrinii was found at only 
one autopsy, its presence as a co-infection with CMV 
was soon to be reported separately by one of the 
authors (Rifkind ef aI.24 ), anticipating this combination of 
infectious agents in the AIDS epidemic that lay ahead. 
INFECTIOUS PULMONARY DISEASE IN PATIENTS 
RECEIVING IMMUNOSUPPRESSIVE THERAPY FOR 
ORGAN TRANSPLANTATION' 
ROllA B. HILL, JR., MD.,t DAVID T. ROWLANDS, Jr., MD.,=!: and 
DAVID RIFKIND, MD., PhD.§ 
DENHR, COLORADO 
Reprinted from N. Eng/. I Med. 271, 1021-1027 (1964) 
Whole-organ homotransplantation is a modality of therapy that has 
only recently been submitted to clinical investigation in man, [ and 
reports on the natural history of patients so treated are therefore 
fragmentary. The clinical course of such patients obviously is pro-
foundly influenced by the chemotherapy that they receive, usually 
including corticosteroids and immunosuppressive antimetabolites. 
These compounds have a wide range of effects on the host metabolic 
reactions. and they so alter immunologic responsiveness that changes 
in the spectrum of infectious disease may reasonably be expected. 
Up to February. 1964, 61 patients had received homotransplants or 
heterotransplants at this center; of these 32 had died after periods 
ranging from one to two hundred and seven days. In 26 of the 32 fatal 
cases active pulmonary infection was demonstrable at autopsy, and in 
3 others, without pulmonary disease, serious infections of other 
organs were present. This study is concerned with the pulmonary 
infections, and reports a high incidence of infection with organisms 
not commonly associated with systemic disease. 
CU'\]CAI A\lD PATHOLOCICAL METHODS 
The patients were selected for transplantation according to criteria 
published elsewhere.2 Renal homotransplants were performed with 
the use of various donors -living relatives, living nonrelatives and 
cadavers; renal heterotransplants were from papio species (baboon). 
Hepatic homo transplants were performed with the use of cadaveric 
donors. For spleniC homo transplants, donors were preimmunized with 
extracts of the recipient· 5 cancer in Freund's adjuvant, in an effort to 
direct the donor spleen's immunologic mechanisms against the 
recipient's cancer. All recipients were deemed to have progressive, 
incurable, fatal disease, and were carefully screened for other disease 
to ensure optimum potentiality for success of the graft. 
Immunosuppression was achieved with azathioprine,'l prednisone 
and actinomycin Ci in accordance with principles previously 
reported.3 ." In general. azathioprine was used for an average of ten 
days before transplantation; in the postoperafive period the dose was 
'From the departments of Pathology and Internal Medicine. 
University of Colorado School of Medicine, Denver, Colorado. 
A preliminary report of this material was presented at the April, 1964, 
meeting of the American /\ssociation of Pathologists and Bacteriologists. 
tRccipient of Lederle Medical Faculty Award; assistant professor of pathol-
ogy. University of Colorado School of 'v!edicine. 
tAssistant professor ot medicine. University of Colorado School of 
Medicine. 
§[n the form of Imuran, Burroughs Wellcome and Company. Tuckahoe, New 
York. 
'\lIn the form of Imuran, Burroughs Wellcome and Company, Tuckahoe, 
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increased to the maximum tolerated (400 to 1000 mg per day), as 
reflected by the appearance of leukopenia. Prednisone, 150 to 400 mg 
daily, was given until the rejection phenomenon was suppressed, after 
which the dosage was decreased and in several cases discontinued. 
Both drugs were temporarily increased at any evidence of rejection, 
and in some cases 2 to 6 doses of actinomycin C 200 jlg daily, were 
added. Azathioprine was continued in a maintenance dose of 3 to 
4 mg per kilogram of body weight per day in all patients. 
At the appearance of clinical infection, therapy in the form of 
specific antimicrobial agents was employed in accordance with the 
results of bacteriologiC studies. 
At autopsy in most cases culture was taken for bacteria and fungi 
from grossly abnormal areas of the lung. In 10, fresh lung tissue was 
homogenized in a medium containing 10 per cent calf serum, quick 
frozen and stored at - 70'C Aliquots were then inoculated into MAF 
and WI-26 lines of human embryonic fibroblasts in the hope of 
demonstrating the specific cytopathic effect of cytomegalovirus. The 
cultures were observed over periods of three or four weeks, and at 
least 1 blind passage was made before this specimen was discarded as 
negative. 
At least 5 specimens of lung from each patient were fixed in 
formalin, and sections stained with hematoxylin and eosin. Periodic 
acid-Schiff, Brown and Brenn, methenamine silver, Ziehl-Neelsen and 
Giemsa stains were employed for the demonstration of micro-
organisms. 
OBSERVATIONS 
All transplant recipients who died during the period of this study 
were autopsied. Table 1 summarizes the facts concerning the type of 
transplant, therapy and infectious pulmonary disease in the 32 fatal 
cases. The cases are listed according to length of survival after 
operation. Where loss of a transplanted organ necessitated a second 
graft, the duration of survival was measured from the initial procedure. 
Twenty-six patients, or 81 per cent of this series. died with 
pulmonary infection. A wide variety of agents were identified, 
including bacteria and fungi, as well as Pnewnocyslis carinii and 
cytomegalovirus. other unidentified organisms of fastidious cultural 
requirements and unusual staining characteristics cannot be ruled out. 
Many patients had multiple infections. Of the 6 patients without 
demonstrable pulmonary infection, 2 had septicemia (due to Escherichia 
coli and paracolon bacillus), and 1 had a wound abscess (mixed 
pyogens). The remaining 3 died of electrolyte imbalance, acute tubular 
necrosis and exsanguinating hemorrhage without demonstrable infec-
tion one, three and eleven days, respectively, after surgery. In 14 
cases, or 44 per cent, the cause of death was clearly related to 
pulmonary infection. 
The infectious agents identified in these lungs are listed in Table 2. 
Of the 45 agents involved, 10 were either common pyogenic bacteria 
or were unidentified, and 7 were pseudomonas species; the remaining 
28 were distinctly uncommon pathogens: cytomegalovirus, 15 cases; 
fungi, 12 cases; and pneumocystis, 1 case. 
Fifteen patients, or 47 per cent. were considered to have cytome-
galovirus infection. This diagnosis was based on the presence of 
enlarged cells with the characteristic inclusions (Fig. 1); basophilic, 
feulgen-negative, intranuclear rounded bodies surround by a clear 
halo. These bodies were found within enlarged nuclei whose chroma-
tin was present in a thin rim. Fine, powdery basophilic material was 
often present also in the cytoplasm adjacent to the nucleus. In 3 cases 
similar inclusions were found in other organs, including the salivary 
glands, lymph nodes, liver, brain, pancreas and parathyroid glands. Of 
the TO patients whose lungs were cultured for this virus, 4 had 
demonstrable inclusions; in no case could the virus be demonstrated in 
culture. It should be pointed out that cytomegalovirus is notoriously 
difficult to isolate, especially from frozen materiaL' and failure to do so 
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TABLE l. Type of Transplant, Therapy Ilnd Infectiol!s Pulmonary Disease. 
CASE 
NcJ. Transplant Sex Age 
yr. 
1 Renal homograft, living donor F 16 
2 Renal homograft, cadaver donor F 42 
3 Hepatic homograft, cadaver donor M 69 
4 Renal homograft, living donor M 50 
5 Splenic homograft M 45 
6 Hepatic homograft, cadaver donor M 53 
7 Renal homograft, living donor M 54 
8 Renal homograft. living donor M 40 
9 Renal heterograft M 36 
TO Hepatic homograft, cadaver donor M 48 
11 Renal heterograft M 40 
12 Hepatic homograft, cadaver donor F 29 
13 Renal homograft, living donor M 35 
14 Renal homograft, cadaver donor M 21 
15 Renal homograft, living donor M 49 
16 Renal heterograft M 45 
17 Renal homograft. living donor F 42 
18 Renal homograft, living donor M 25 
[9 Renal homograft, cadaver donor M 29 
20 Splenic homograft M 53 
21 Renal homograft, living donor M 21 
22 Renal homograft, living donor F 25 
23 Renal homograft, living donor M 20 
24 Renal homograft, living donor M 39 
25 Renal homograft, living donor M 20 
26 Renal homograft, living donor M 41 
27 Renal homograft, living donor M 25 
28 Renal homograft, living donor F 44 
29 Renal homograft, living donor M 17 
30 Renal homograft, living donor M 34 
31 Splenic homograft M 47 
32 Renal homograft, living donor M 30 
by no means invalidates the diagnosis. The frequency of infection with 
this agent was greater in the patients with the longest survival 
(Table 1): 7 of the 8 who survived for more than sixty days were 
infected. The incidence of infection had no relation to the age of the 
patient (Table 3) 
An unusual spectrum of histologic reactions to the infectious 
organisms was present. This was presumably due to alterations in 
cellular immune mechanisms and bone-marrow suppression brought 
about by transplantation and immunosuppression. In a few cases a 
classic bronchopneumonia was seen, with diffuse or peribronchial 
congestion, edema and polymorphonuclear infiltration. A characteris-
tic pattern, however, most commonly associated with candida and 
pseudomonas infection, was the appearance of widespread but sharply 
limited lesions (Fig. 2). In these, a small number of alveoli were filled 
with blood and proteinaceous fluid, usually in the vicinity of a small 
arteriole whose wall was massively invaded with bacilli or fungi. 
These lesions were remarkable for the absence of polymorphonuclear 
leukocytic reaction. In 1 case lesions of this type were so closely 
associated with the presence of inclusions that an etiologic relation is 
suggested, but in others. no-tissue reaction was evident. 
Poor or absent leukocyte response was a common feature. In 1 case, 
for instance (Case 26), abscesses containing amorphous debris and tiny 
gram-negative bacilli were in the midst of regions of alveoli packed 
with macrophages containing large numbers of similar organisms. No 
polymorphonuclear leukocytes were present (Fig. 3). The organism 
did not grow in culture. In another patient (Case 19) staphylococcal 
abscesses. which are classically associated with a brisk polymorpho-
Survival 
after 
Transplant Prednisone Therapy Azathioprine Therapy 
duration dose range duration dose range 
days days mg days mg 
1 0 10 150-200 
3 4 200-250 4 200-400 
8 21 50-100 21 150--600 
]l 5 75-100 9 375-1000 
11 4 50-320 11 150-750 
15 1 75 13 200-300 
15 9 180-200 26 100-400 
17 6 200-300 20 150-400 
19 21 150-200 22 75-350 
22 22 0-200 22 50-400 
23 27 100-200 32 100-350 
23 23 50-300 24 100-600 
24 21 80-425 26 150-400 
25 12 20-150 23 100-1000 
25 11 50-200 29 200-400 
36 2 150 43 JOO-250 
37 32 30-400 35 150-500 
37 37 60-200 30 100-400 
40 6 30-45 31 100-900 
41 38 30-200 41 150-400 
41 30 100-240 45 100-500 
43 43 100-200 62 100-300 
48 45 60-200 52 150-400 
48 45 5-230 41 125-440 
62 55 15-200 63 250-750 
76 76 75-200 103 100-400 
79 79 5-400 80 JOO-600 
83 77 5-200 88 150-400 
95 88 20-400 103 100-350 
113 99 10-100 120 100-900 
142 142 5-30 146 JOO-250 
207 201 10-315 213 100-400 
nuclear response, were marked by peripheral granulation tissue and a 
mild to moderate lymphocytic reaction. 
A particularly violent necrotizing effed of fungal organisms was 
noted. In all 10 cases of candidiasis, as well as in those of aspergillosis 
and nocardiosis, fungal hyphae and pseudohyphac were associated 
with necrosis characterized by abundant "nuclear dust," abscesses, 
thick, proteinaceous exudate and variable but usually minimal 
polymorphonuclear reaction (Fig. 4). 
Mixed infections were common. In only 4 cases was cyto-
megalovirus unaccompanied by another infectious agent, such as 
pseudomonas, candida, pneumocystis (Fig. 5) or nocardia. In at least 4 
cases 3 microbial agents were present concurrently (Table 1). 


















CLASSIC PAPER 7 
TABLE 1. (Concluded) 
No. of Doses Clinical 
CAoE of Actinomycin Evidence Pneumonitis 
No. C (200 Microgm) of Pneumonia at Autopsy Responsible Organisms Inclusions Cause of Death 
0 0 0 Electrolyte imbalance 
2 0 0 Minimal Uremia 
3 0 0 + Cytomegalovirus; candida sp. + Pulmonary infarct 
4 0 + + Cytomegalovirus; Pseudomonas + Sepsis (pseudomonas) 
aemginosa. 
5 3 0 0 Rupture of spleen; carcinoma of 
stomach, metastatic. 
6 0 0 + Mycobacterium luberculosis Pulmonary emboli 
7 5 + + Pseudomonas sp. Pulmonary infarct 
8 7 0 0 Sepsis (para colon bacillus) 
9 4 0 + Klebsiella Uremia 
10 9 0 + Gram-negative rods; candida sp. Pulmonary infarct 
11 4 + + Candida sp.; Ps. lIerHginos!I. Pulmonary infarct 
12 4 0 0 Peritonitis (Escherichia co/i) 
13 IT 0 0 Congestive heart failure 
14 6 0 0 Cytomegalovirus + Sepsis (pseudomonas) 
15 2 + + Cytomegalovirus; Esch. Coli;M. + Sepsis IEsch. coli}; pulmonary 
tuberculosis. emboli. 
16 9 + + Cytomegalovirus; Ps. aeruginosll. +++ Uremia; pulmonary emboli. 
17 31 0 + ? Septic pulmonary infarct 
18 6 + + Aspergillus fumiguilts; Candida Sepsis (aspergillus & candida) 
albicarls. 
19 2 + + Staphyio[(Jccus aureus Exsanguination 
20 0 + + Cytomegalovirus; Candida +++ Pneumonia 
stellaloidea. 
2! 2 0 + Cytomegalovirus; candida sp. + Pyelonephritis; myocarditis. 
22 8 0 + Diplococcus pnetJmoniae Uremia; peritonitis (D. 
pneumoniae). 
23 6 0 0 Cytomegalovirus ++ Congestive heart failure 
24 2 + + Ps. aeruginosa Sepsis (Pseudomonas) 
25 15 0 0 Cytomegalovirus ++++ None known 
26 15 + + Cytomegalovirus; candida sp.; gram- +++ Sepsis (candida) 
negative intracellular rods. 
27 22 + + Cytomegalovirus; candida sp.; Pi. +++ SepSis (pseudomonas & candida) 
aemginasa. 
2S 27 0 0 Cytomegalovirus ++++ Pancreatitis 
29 20 + + Cytomegalovirus; PllelJmacystis ++ Pneumonia (pneumocystis) 
mrinii. 
30 11 + + Candidi sp.; 1'5. aentgino5a. Sepsis (candida & pseudomonas) 
31 0 0 + Cytomegalovirus; gram-positive cocci. +++ Pneumonia; carcinoma of stomach. 
metastatic. 
32 38 + + Cytomegalovirus; C. albicalls; + Generalized nocardiosis 
Nomrdia a5leroidcs. 
Clinical evidence of biologic response to the infecting 
organisms was lacking in a high percentage of patients. Fifty per cent 
of those who had pulmonary infection at autopsy had not given 
evidence of this infection clinically. Four were due to cytomegalovirus, 
I to Mycobacterium tuberculosis, 3 to candida species, and the remain-
ing 5 to various bacteria. In some cases there was lack of tissue 
response to the infecting organism, and in others lack of general 
response in terms of fever, leukocytosis and so forth. 
TABLE 3. Disfrilmlion of Cytomegalovirus Infection According 10 Age. 
No. with Percentage 
ACE GROUP No. of Patients Inclusions with inclusions 
yr. 
16-29 11 6 54 
30-39 5 1 20 
40-49 11 5 45 
50-70 5 3 60 
No clear relation between daily drug dosage and severity or type of 
infection emerges from this study. On the other hand, it is evident 
that survival and cumulative drug dosage correlate with the incidence 
and type. All the patients dying without demonstrable infection lived 
for less than twenty-four days after transplant. All the patients with 
triple infections, on the other hand, lived for more than twenty-four 
days. The incidence of fungous and cytomegalovirus infections 
increased with length of survival. 
DISCuSSION 
The transplant recipient has joined the growing legion of patients 
whose therapist treads a think, barely observable line: too little 
8 
j-IGLRF J . PlwtmHlCTC'!!mIJh of the LHllg in Case 27 III:;"" Slain X6 50l, 
Tw,' <11i.,meg" lic [d/<. ",'e wif), hao ttffecled IIlfe ,' i, 1m prrscllt. Cllamciaisli{ me Ihe 
iHfp-mllldt'nr ruril(si{JHS, pry;phernl rim of Ill /clenr cilromnfill md large m/{~D:;R 0. cylLJ-
J'/osm. In 1I1(IJIY (IbCS. Ilrt' ry foplll"lll also Otl tnl lf5 smn/ , grmlflJar basvphilic iJlciu5jOIlS. 
therapy, and the patient succumbs to his biologic abnormality; and too 
much, and a new constellation of unrelated but equally ominous 
pathologic processes arises, To find and stay on the narrow middle 
road requires alert individualization of dose and a considerable 
delicacy oi response to changes in the patient's condition. Of the 32 
transplant recipien ts in this seri es, death in 26 was related to 
complications of therapy, usually infection. 
The 26 patients who had pulmonary infection at death are the 
subject of this report. All patients received azathioprine and pred-
nisone, and some ac tinomycin C (Table 1), and the administration of 
each of these drugs is known to be associated wi th an increase in 
incidence of infection. The anti -inflammatory action of cortisone,6 the 
inhibition of RNA syn thesis by actinomycin 7 and the "immuno-
suppressive" and bone-marrow-depressant actions of azathioprine8 .9 
arc usua lly invoked, but additional mechanisms deserve consideration. 
rhc anti-inflammatory effect of cortisone and related compounds 
has been known fo r a long time, but a finn biochemical basis for this 
ha s not been es tablished. Among the biologic effects of ad renocortical 
hormones are the inhibition of fibroblast replication and collagen 
production, to inhibition of chemotaxis, I [ lysis of lymphoid tissues !> 
and suppression of the formation and activity of interferon . [J An 
interesting recent observation is that of Weissmann and Thomas, 14 
fw rpl" /lelil'll iled ReglO" 0 A h'ed "r Hemorrhage and Edema in Case 21 
II leJl lI/to_flr/i ll Imr! [osill Slain X65). 
Till '; Fa lie/lf had rm:nlt-ia film iKK"y to ll l c~{/ ioviruA il1fecNo1l5, but inclHsiol"!5 were rwl clearl.lf 
"e/a/,rl fo Ilrt l'ocr of /1" 1)lpr il/uslraled. 
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F,GURF 3. Fielrl Adjacenllo an Abscc; in Case 26 (Hemaloxylili owl Eosin 510ill X 100). 
The alveoli nre Iiller! wilh maerophagl's who" .. voluminous cytoplasm em. be de", ol1 -
s/rated wilh special sla;II5 10 con/aill Ili rge "", ,,llCrs oj 51/1nl/ Rmm-llcgl1lwe rnrls. No 
tlmfe illf1anmrni ory rC'nC/ imr 15 pre~eD liK 
who ha ve demonstrated stabilization of the lysosomal membrane by 
certain corticoids. The lysosome, an intracellular membrane-enclosed 
sac of lytic enzymes, is concei ved of by deDuve, " ov ikoff,' 6 and 
Hirsch 17 and others as instrumental in the intracellular digestion of 
phagocytized partides; if Iysosomes were so stabilized by corticoids 
that their complement of enzymes could not reach and digest 
phagocytized parasites, these parasites would presumably multiply 
and kill the host cell. That cortisone may indeed act in this way is 
given support by the experiments of Iwata et aI., '" who demonstrated 
germination of phagocytized aspergillus spores intracellularl y in 
isolated peritoneal leukocytes from corti sone-treated animals, but not 
in cell s from control an imals. 
Some controversy exists regarding the effect of the actinomycins 
on immune responses 19; their demonstrated primary action is com-
plete inhibition of DNA-dependent RNA synthesis. and thus second-
ari ly inhibition of protein synthesis, presumably through lack of 
appropriate messenger RN A.7 The effect in both in vitro and in vivo 
systems is immediate and lasts no more than two days, and in the 
experiments in which an effect on immune-globulin production has 
been demonstrated, the effect was a delay in antibody synthesis, not 
total inhibition '9 Since doses of actinomycin C in the pa tients in this 
lGUR£ 4, Seclion il1 e n e 32, Showillg an Abscess, '" W hic], Noccr rdia Hyphae Are 
Numcrolls, Drnl Is Swro!lluleri b~ n C/or,,;/ of DegcllenrlinR Cells, uc/l!Jlr Debris and 
Mailed Hyphae (Hemaloxylil1 mId Eos;n Slain X35 - - blScr'i ; Brown-Brenn Slain of 
Fwrgnl Hyphae X675). 
TIre adjCleeli1 alveolnr seplums are Ihickwed, and macropiJages me prese,,/ ill fhe alveoli. 
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se ries were infrequent and widely spaced they presumably acted in 
acute situations such as imminent rejection crises, 20 rather than on 
immune mechanisms related to smoldering infections. 
Azathioprine, an imidazole derivative of 6-mercaptopurine. has had 
widespread use as an immunosuppressive drug in the past few years. 
Its effect appears to be similar to that of 6-mercaptopurine," but 
available data suggest that it may have a higher therapeutic index in 
suppression of the renal-homograft response.21 Bone-marrow suppres-
sion, entirely similar to that seen in 6-mercaptopurine therapy. occurs 
regularly with higher doses. An increased incidence of infection is 
therefore not unexpected. Although suppression of immune response 
to infectious agents by this drugs has not been demonstrated. 
depression of antibody rL'sponse to other antigenic proteins has been 
reported." 
The specific drug effects that are directly responsible for such an 
unusual spe ctrum of diseases are unknown, as are the possible 
profound effects of the continued interaction of foreign protein (in the 
form of the transplanted kidney) and the host . The predominance of 
fungous and viral infectious in particular is intriguing. A recent 
editorial by Beeson22 calls attention to the unexplained association of 
specific infectious agents with specific noninfectious diseases. citing 
mucom,ycosis and diabetes, salmonellosis and sickle-ce ll disease, 
disseminated herpes zoster and chronic lymphocytic leukemia, pneu-
mococcal peritonitis and the nephrotic syndrome, candidiasis and 
hypoparathyroidism.22 Attention has recently been called to the 
association of nocardiosis and pulmonary alveolar proteinosis. 2 Cor-
ti sone trea tment of rabbits and rats has frequently been associated 
with pneumocystis pneumonia.24. i and the intriguing observation has 
recently been made that pneumocystis pneumonia in children may 
occur during tapering of prednisone therapy as the dose drops below 
1 mg per kilogram of body weight per day 00 A similar association of 
fungoLis infections with prolonged antimetabolite and co rtisone 
therapy is suggested in the present report. The studies of Sidransky 
et al.17. 28 showing enhanced germination and poor host response to 
aspergillus in cortisone-treated and antimetabolite-treated mice may 
be further evidence for this view. 
The part played by bone-marrow depression in these infections is 
difficult to assess . Bone-marrow aspi rations and biopsies were not 
performed regularly during life, and the state of the bone marrow at 
death obviously bore no necessary relation to its state during the 
postoperative course of the patient. Hypoplasia of the bone marrow, 
9 
present in many of these cases at death, could not be correlated with 
severity or type of infection, and a normal bone marrow was present 
in some cases notable for the absence of leukocytic response to the 
infecting organism. It seemS reasonable to hypotheSize that infections " 
arising during periods of bone-marrow depres,iCln could not be 
re versed by re-establishment of a normal marrow. 
Clinical disease caused by cytomegalovirus has been recognized 
largely in premature or debilitated infants. The wide asymptomatic 
distribution of the virus is attested to by its presence in the sali vary 
glands of 10 per cent of infants at autopsy. and by the demonstration 
of complement-fixing antibodies to the agent in about 80 per cent of 
adults past the age of thirty- fi ve years. , .. ,q The data presented here, 
with 15 of 32 autopsied patients showing infection, support the 
concept of a wide distribution of the virus among the population. 
Page, Condie and Good30 have recently suggested that 
6-mercaptopurine is virucidal in patients with chronic hepatitis, but an 
inhibitory effect of a closely related drug, 3lathioprine, on virus 
replication is not suggested by this study. The high incidence of 
demonstrated cytomegalovirus infection has been mentioned. Study 
of the brains of these autopsied patients suggests the presence of vi ral 
infections in a very high incidence.'! Prolonged survival and patho-
g enicity of hepatitis virus is inferred in a kidney-transplant recipient. 
not included in this report. who has had smoldering acute hepatitis for 
six months while under continuous prednisone and azathioprine 
therapy . Patholog ica l examination of a recent liver biopsy re veals 
continuing active acute hepatitis, without cirrhosis or the usual 
features of chronic hepatitis ,''' 
SUMMARY 
Pulmonary infections were present terminally in 26 of 32 patients 
dying one to two hundred and seven days after recei vi ng an organ 
transplant . The responsible organisms included a large number of 
unusual agents not commonly prodUCing clinical disease. Candida, 
aspergillus, nocardia, pneumocystis and cytomegalOVirus were ident-
ified in 28, and va rious bacteria, notably pseudomonas, in 17 cases. 
Multiple infections were common . The metabolic effects of the 
immunosuppressive drugs and corticosteroids received by these 
patients are discussed in relation to the high incidence of unusual 
infections. 
Since this report was submitted for publication 7 more patienh have died 
after survivals of thirty-seven to one hundred days. All 7 had pulmonary 
infections, including 5 wi th cytomegalovi rus, 2 with aspergillus, 2 with 
pneumocystis, 2 with candida, 2 with pseudomonas, 2 \\'ith Staph. MlrellS and 1 
with tiny gram-negative intracellular bacilli si milar to those seen in Case 26. 
Recently. one of us (D.R.) isolated a cytopathogenic agent, apparentl y 
cytomegalovirus. from the lungs of 2 patients in whom inclusion bides had 
been demon strated histologically at autopsy. 
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COMMENTARY 
Early workers in transplantation25 .26 including Hill, 
Rowlands and Rifkind recognised the resemblance of 
allograft rejection to the response against infections 
associated with delayed hypersensitivity, as exemplified 
by tuberculosis. With the demonstration of the MHC 
restricted mechanisms of adaptive infectious immunity by 
Doherty and Zinkernagel in 197327- 30 it seemed obvious 
that allograft rejection must be the physiological equiva-
lent of the response to this kind of infedion. 
Microorganisms that generate such an adaptive 
immune response are generally intracellular, and have no 
or low cytopathic qualities.31 Although MHC-restrided 
host cytolytic T lymphocytes recognise only infeded 
cells, elimination of all the infected cells could disable or 
even kill the host. Consequently, mechanisms have 
evolved that can temper or terminate the immune 
response, allowing both host and pathogen to sur-
vive.3 1.32 They are the same mechanisms that allow 
survival of allografts.33 
The highly variable clinical manifestations of these 
mechanisms can be illustrated by the different outcomes 
that may follow an infection with disseminated non-
cytopathic microorganisms (e.g. CMV and other patho-
gens identified by Hill, Rowlands and Rifkind, or the 
common hepatitis viruses). These are shown in Figure 2, 
with transplantation analogies shown below each panel. 
After a rapid increase during the so-called latent period of 
a non-cytopathic infection, the pathogen load may be 
dramatically and efficiently reduced by antigen-specific 
effector T-cells, following which the CTL subside (Figure 
2, left panel). The events are analogous to those of 
rejection in an untreated or inadequately immunosup-
pressed transplant recipient. Alternatively, such infections 
may lead to a continuously high antigen load and an 
antigen specific immunologic collapse (Figure 2, second 
panel), equivalent to allograft acceptance (and tolerance). 
Persistence of the infectious agent with an unrelenting 
immune response (Figure 3, third panel) may result in 
serious immunopathology (e.g. chronic active hepatitis 
with HBV or HCV infedion), analogous to either chronic 
rejection or uncommonly graft versus host disease 
(GVHD). 
Although the relation between allograft rejedion and 
the adaptive immune reaction against non-cytopathic 
microorganisms was unmasked by the discoveries of 
MHC restriction, the means by which antigen specific 
non-reactivity (tolerance) is induced has remained one of 
the most controversial questions in biology. Zinkernagel 
has approached the enigma with experimental models 
that place viral and transplantation immunity on common 
ground.31 .32,34 
Using transgenic techniques, colonies of donor animals 
are produced whose transgenes express viral epitopes, 
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Figure 2. Variable outcomes after infection with widely disseminated non-cytopathic viruses (or other microorganisms) and analogies (given below 
each panel) to organ and bone marrow transplantation. The horizontal axis denotes time, and the vertical axis shows the viral load (v, solid line), 
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Figure 3. The four events that occur in close temporal approximation when there is successful organ engraftment: above, double acute clonal 
exhaustion (1,2) and subsequent maintenance clonal exhaustion COl) plus, below, loss of organ immunogenicity due to depletion of the graft's 
passenger leukocytes (4). (By permission of Nature Med. 4, 1006-1007, 1998). 
but are otherwise syngeneic with recipients, in effect 
creating a highly defined minor histocompatibility barrier 
(e,g. the gp33 peptide of LCMV). Alternatively, recipient 
effectors that playa known role in responding to speCific 
viral epitopes such as gp33 can be modified or replaced . .34 
With these technologies, it has been possible to pool 
information in viral immunology (particularly that 
acquired about LCMV) with that of transplantation 
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Table 2. Central therapeutic dogma of immunosuppression 
Strategy Baseline agents Sites of inhibition 
1. Baseline therapy with one or two drllgs 






Interleukin-2 production 3. Case to case trial (and potential error) of weaning. 
°Equivalent results with cyclophosphamide. 
immunology and penetrate the mystique of 
tolerance.35 
Under circumstances of either a non-cytopathic infec-
tion or transplantation, antigen specific non-reactivity 
requires only two mechanisms, both of which are con-
trolled by antigen migration and localisation.33 A pre-
requisite for the first of these, clonal exhaustion/deletion, 
is antigen presentation to organised lymphoid collections 
in lymphoid organs (i.e. spleen, lymph nodes, bone mar-
row, thymus) or in ectopic locations (e.g. the graft itself). 
It was recognised in 1992 that this prerequisite was being 
met after organ transplantation by the lymphoid oriented 
migration of passenger leukocytes from transplanted 
organs. The result was widespread immune activation of 
the recipient, leading to clonal exhaustion. B ,36.37 More 
importantly, survival of the donor derived leukocytes for 
up to 30 years in 30 of 30 recipients with continuously 
functioning organ allograf!:s implied an ongoing role for 
th . h I' d 113330-38 ese penp era Ise ce s ,. . 
The second mechanism of non-reactivity is avoidance 
by the antigen of lymphoid collections, thereby preclud-
ing rather than causing efficient immune activation. This 
strategy is exemplified in infectious disease by the 
migration routes of rabies and wart viruses, and in 
experimental transplantation models by pre-transplant 
depletion of passenger leukocytes from the allo-
graft33,36,37 (Figure 2, right panel). 
The two mechanisms can be readily identi[-ied in most 
infections, but their study is complicated in most trans-
plantation circumstances by the presence of two popula-
tions of immune competent cells (i.e. donor as well as 
reCipient), each of which can induce tolerance to the 
other. 33,36 -38 With the chimerism discoveries in 1992, it 
was possible to explain the results accomplished with the 
combined use of azathioprine and prednisone in 1962-63, 
and why in later years, the treatment algorithm devel-
oped with these drugs (Table 2) readily accommodated 
the replacement of azathioprine by more potent T-ce1l 
directed baseline drugs (i.e. cyclosporine and tacrolimus). 
The same applied to a succession of adjunct agents: 
antilymphocyte globulin and other antilymphoid prepa-
rations, mycophenolate mofehl and other 'second line' 
drugs. 
The results with kidney transplantation improved with 
the more potent drugs, and it became possible to 
effectively transplant a full spectrum of extrarenal organs. 
However, the characteristic cycle of immune activation 
and various degrees of subsequent immune exhaustion, 
aided by an element of secondary immune indifference, 
has remained the same. For organ engraftment to occur, 
four interrelated events, all regulated by antigen migra-
tion and localisation33 must occur in relatively close 
temporal proximity3S-38 (Figure 3): (1) and (2), reciprocal 
antigen specific clonal exhaustion/deletion of the host 
versus graft and graft versus host immune reactions, (3) 
maintenance exhaustion, and (4) reduction of the 
leukocyte-depleted allograft antigenicity, making the 
transplanted organ an object of 'immune indifference' to 
the host immune system. 
Because immunity and tolerance to alloantigens follow 
the same rules as the response to microbial antigens/3 it 
is not possible with current transplantation practices to 
induce tolerance to allografts on one hand without 
risking unwanted tolerance to pathogens on the other. 
Furthermore, conventional bone marrow transplantation 
is only a mirror image of the events after organ 
transplantation33,36-38 with the same governance of the 
immune events by antigen migration and localisation.33 
Although pretransplant cytoablation renders the recipient 
subject to GVHD, the host leukocytes are not all 
eliminated.39 The weak host versus graft reaction 
mounted by the remaining recipient cells, and the parallel 
graft versus host reaction of the donor cells can 
eventually result in reciprocal tolerance, all the while 
with the threat of undesirable induced non-reactivity to 
pathogens. 
Given the historical perspective of this classic paper, 
what does the future hold? If strategies to develop 
xenotransplantation are to be developed, it must be 
recognised that the barrier to xenografts is analogous to 
the immune defense against cytopathic microorganisms of 
the kind that were underrepresented in the cases reported 
by Hill, Rowlands and Rifkind. 1 These pathogens are 
typically extracellular and activate the full resources of 
the innate as well as the adaptive immune system.31 
Because there is no MHC-restricted safety valve, an 
uncontrollable innate immune response is provoked by 
discordant xenografts expressing the gal-alpha-1,3-gal 
carbohydrate linkages, an epitope which also is found on 
numerous cytopathic bacteria, protozoa and viruses.4o 
The clinical use of such discordant animal donors will 
require changing the xenogeneic epitope to one that 
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mimics a non-cytopathic profile.,u Blocking activation of 
complement (reviewed in42) will not suffice. The alterna-
tive is elimination of the xenogeneic epitope, an objective 
currently beyond reach in the pig (the most widely 
advocated donor animal) because of the unavailability of 
stem cells for gene deletion in this species. However, if 
these innate responses can be avoided, then we can 
anticipate problems from non-cytopathic viruses such as 
those described in this classic paper. 
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